Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 15;116(20):4872-81.
doi: 10.1002/cncr.25215.

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey

Judith Swan  1 , Nancy Breen, Barry I Graubard, Timothy S McNeel, Donald Blackman, Florence K Tangka, Rachel Ballard-Barbash
Affiliations

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey

Judith Swan et al. Cancer. .

Abstract

Background: This paper examines the prevalence of cancer screening use as reported in 2005 among US adults, focusing on differences among historically underserved subgroups. We also examine trends from 1992 through 2005 to determine whether differences in screening use are increasing, staying the same, or decreasing.

Methods: Data from the National Health Interview Surveys between 1992 and 2005 were analyzed to describe patterns and trends in cancer screening practices, including Papanicolaou test, mammography, prostate-specific antigen, and colorectal screening. Logistic regression was used to report 2005 data for population subgroups defined by several demographic and socioeconomic characteristics.

Results: Rates of use for cancer tests are rising only for colorectal cancer, due largely to the increase in colorectal endoscopy screening. Use of all the modalities was strongly influenced by contact with a physician and by having health insurance coverage.

Conclusions: There remain large gaps in use for all screening modalities by education, income, usual source of care, health insurance, and recent physician contact. These specific populations would benefit from interventions to overcome these barriers to screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.
Figure 1
Figure 1
Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.
Figure 1
Figure 1
Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.
See this image and copyright information in PMC

References

    1. U.S. Department of Health and Human Services . Healthy People 2010: Understanding and Improving Health. 2nd ed. U.S. Government Printing Office; Washington, DC: 2000.
    1. U.S. Preventive Services Task Force . Guide to Clinical Preventive Services, Third Edition: Periodic Updates. Agency for Healthcare Research and Quality; Rockville: 2002.
    1. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548–552. - PubMed
    1. Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control. 1998;9:519–527. - PubMed
    1. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:636–644. - PubMed

MeSH terms

Substances